In 2025, the sector in Qatar registered a market revenue of USD 468.4 million.
Our research projections indicate the Qatar Infusion Services Market is forecast to reach USD 1.40 billion by 2033, reflecting a CAGR of 14.7% over the forecast period.
Centralized healthcare planning under Hamad Medical Corporation supports structured infusion delivery with strong biologic access discipline.
Qatar’s National Cancer Strategy publications indicate continued investment in oncology services, sustaining systemic therapy throughput growth.
DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation.
[Learn more]